
Sign up to save your podcasts
Or
We love to hear from our listeners. Send us a message.
Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Severino discusses why delivery has always been a challenge for gene editing technologies and why Gene Writing is different when it comes to efficient delivery.
Subscribe to the podcast!
Apple | Spotify | YouTube
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Severino discusses why delivery has always been a challenge for gene editing technologies and why Gene Writing is different when it comes to efficient delivery.
Subscribe to the podcast!
Apple | Spotify | YouTube
757 Listeners
177 Listeners
30,845 Listeners
3,195 Listeners
32,291 Listeners
2,648 Listeners
272 Listeners
318 Listeners
29 Listeners
2,135 Listeners
147 Listeners
18 Listeners
15 Listeners
54 Listeners
152 Listeners